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Immunology
Synthesis of i'mmunoglobulin gu chain gene products precedes
synthesis of light chains during B-lymphocyte development
(pre-B lymphocytes/fetal liver/immunoglobulin mRNA)
E. SIDEN*t, F. W. ALT*, L. SHINEFELDf, V. SATOt, AND D. BALTIMORE*
*Center for Cancer Research and Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139; and Mlhe Biological Laboratories,
Harvard University, Cambridge, Massachusetts 02138
Contributed by David Baltimore, November 24, 1980
ABSTRACT Immunoglobulin (Ig) gene expression has been
followed during the later stages of development of the murine
fetal liver. Biosynthetic labeling and immunoprecipitation were
used to isolate Ig-related polypeptides from fetal and neonatal liv-
ers. By examination of the specific immune precipitates, the ear-
liest detectable Ig was shown to consist only of p heavy chain. At
about the time of birth, when light chain synthesis became evi-
dent, separation of surface Ig-positive cells from surface Ig-neg-
ative cells by using anti-Ig-coated dishes showed that cells lacking
surface Ig (pre-B lymphocytes) synthesized only ,u chains. Thus,
commencement of light chain synthesis was closely coordinated
with the appearance of surface Ig. Ig RNA species were examined
by electrophoretic fractionation and hybridization with cloned Ig
DNA sequences. The sizes and amounts of Ig mRNA were found
to correlate with the pattern of p and light chain protein biosyn-
thesis. p chain RNA species appeared earlier in gestation than
light chain RNA did, and only after birth did light chain sequences
reach levels equivalent to those of , chain. Cell populations en-
riched in pre-B lymphocytes also contained an excess of p over
light chain mRNA.
A suggestion that pre-B lymphocytes might lack a light chain
has come from analyses of surface Ig-negative lymphoid tumor
cells (9-12). Many clonal lines of mouse bone marrow cells
transformed in vitro by Abelson murine leukemia virus (A-
MuLV) (13) make only cytoplasmic Au heavy chains but no light
chains (10). To explain this observation, it was suggested that
the "p-only" phenotype might be characteristic of normal pre-
B cells. Subsequently it has been found that early fetal pre-B
lymphocytes (14) and hybrids derived from fusion of myeloma
and fetal liver cells (15) also express only cytoplasmic ,t heavy
chain.
To investigate the time course of Ig gene expression in de-
veloping mouse embryos, we have analyzed Ig mRNA accumu-
lation and protein biosynthesis throughout late ontogeny. We
have found that both heavy chain protein and mRNA are de-
tectable earlier in development than light chain gene products
and are enriched in cells that do not express surface Ig.
Fetal murine B lymphopoiesis is detected earliest in the pla-
centa (1) and becomes evident in the fetal liver after 13 days of
gestation (2-4). After birth, the bone marrow becomes the
major site of primitive B-lymphocyte development. During the
development of B lymphocytes, many cellular changes occur,
the most obvious involving the types of immunoglobulin (Ig)
molecules produced by the cells. Mature antibody-secreting
cells make complete Ig molecules, consisting of both heavy and
light chains. Virgin cells in embryonic or neonatal mice prob-
ably make Ig molecules with heavy chains restricted to the ,u
class and either K or A light chains. Their precursors, the pre-
B cells, were first described as cells that also make complete
Ig, ,u heavy chain, and a light chain (2, 5); they were distin-
guished from their more mature progeny because pre-B lym-
phocytes lacked surface Ig whereas B lymphocytes had surface
Ig.
An important difference between unstimulated B lympho-
cytes and their antigen-stimulated, antibody-secreting progeny
involves the COOH-terminal end of the ,u chain. Unstimulated
cells make primarily membrane-bound Ig as a consequence of
the occurrence of a membrane-binding domain at the COOH
terminus of the ,u chain (6-8); this ,u chain protein is designated
"Um." In secreting B lymphocytes or plasma cells, the A chain
protein has a COOH terminus that allows secretion of the pro-
tein; this protein is called "As.'" The two forms of A chain are
encoded by distinguishable mRNAs: a 2.7-kilobase (kb) mRNA
for An and a 2.4-kb mRNA for As (6, 7). The 3'-terminal portions
of these mRNAs come from different exons in the constant p.
chain region of cell DNA (8).
MATERIALS AND METHODS
Buffers. Buffer I contained 8.29 g of NH4Cl, 1.0 g of
KHCO3, and 0.074 g of Na2EDTA per liter (pH 7.4). Immu-
noprecipitation buffer contained 0.1 M sodium chloride, 10mM
sodium phosphate buffer (pH 7.4), 1% Triton X-100, 0.5% so-
dium deoxycholate, 0.1% sodium dodecyl sulfate, 1 mM phe-
nylmethylsulfonyl fluoride, aprotinin (20 pg/ml; Boehringer
Mannheim), 1 mM Na-tosyl-L-arginyl methyl ester, 1 mM
EDTA, and bovine serum albumin (1 mg/ml). Labeling me-
dium was Dulbecco's modified Eagle's medium lacking methi-
onine and supplemented to 10% (vol/vol) with dialyzed fetal
calf serum containing 10 mM Hepes buffer (pH 7.35), penicillin
(50 units/ml), and streptomycin (50 ,g/ml). Sample buffer con-
tained 50 mM Tris'HCl (pH 6.8), 50 mM dithiothreitol, and 1%
sodium dodecyl sulfate. Standard saline citrate was 150 mM
NaCV15 mM Na citrate.
Preparation of Fetal Liver Cell Suspensions. All experi-
ments used BALB/cAn mice raised in our own colony. Vaginal
plugs were observed on day 0 and birth occurred 19 days later.
Livers were removed from washed embryos or neonates and
were placed into room temperature RPMI-1640 medium/10%
(vol/vol) fetal calf serum/10 mM Hepes buffer, pH 7.35. Single
cell suspensions were prepared by gently squeezing the livers
through nylon mesh (netex) with a plunger from a 3-ml dispos-
able syringe. The cells were constantly flushed through the
mesh with medium. Large debris was allowed to settle and the
cells were washed two times with medium. Erythrocytes were
Abbreviations: Ig, immunoglobulin; A-MuLV, Abelson murine leuke-
mia virus; kb, kilobase.
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removed either by ultracentrifugation as described below or by
treatment with buffer I. To treat with buffer I, washed cells
were resuspended in that buffer at 108 cells per ml for 1 min
at 0TC. Four volumes of cold phosphate-buffered saline was
quickly added, and the cells were washed two times in phos-
phate-buffered saline before labeling.
Fractionation of Cells with Surface Immunoglobulin. To
remove erythrocytes, washed cells from 12- to 19-day livers
were resuspended gently with a wide-bore pipette in 7 ml of
35% (vol/vol) Path-O-Cyte V (Miles). This cell suspension was
layered under cold medium in a 2.5 x 8.9 cm nitrocellulose
tube for the Beckman SW27 rotor and centrifuged at 4TC for
30 min at 10,000 rpm to pellet the mature erythrocytes. The
nucleated cells that banded at the interface were washed two
times with medium containing 10% fetal calf serum (GIBCO)
and resuspended at 107 cells per ml. Three milliliters of cells
were fractionated on each petri dish coated with rabbit anti-
mouse Ig as described (16). The nonadherent population was
washed once with labeling medium, and before labeling the
adherent cells were washed once while still attached to the petri
dishes.
Biosynthetic Labeling, Immunoprecipitation, and Electro-
phoretic Analysis. After washing, cells were resuspended at
5-50 x 106 nucleated cells per ml in labeling medium.
[3S]Methionine (New England Nuclear) was added to 100 tkCi/
ml (1 Ci = 3.7 x 1010 becquerels), and the cell suspensions
were labeled in a humidified CO2 incubator for 2 hr at 37TC.
The cells were then washed once with cold phosphate-buffered
saline and resuspended at 107 cells per ml in cold immunopre-
cipitation buffer. Each milliliter of lysate to be precleared was
incubated with 5 /.l of normal rabbit serum and 25 p1 of 10%
(wt/vol) fixed Staphylococcus aureus bacteria in immunopre-
cipitation buffer for 2 hr at 0TC. The lysates were then centri-
fuged for 1 hr at 100,000 x g before addition of specific anti-
serum. Incubation was continued for 16-24 hr at 4°C followed
by precipitation of the immune complexes with whole formalin-
fixed S. aureus as described (17). Precipitates were washed
twice in immunoprecipitation buffer and resuspended in sam-
ple buffer for sodium dodecyl sulfate gel electrophoresis and
boiled for 1 min. Samples were analyzed on 12.5% (wt/vol)
polyacrylamide gels with sodium dodecyl sulfate as described
(18). The gels were fixed in 25% (vol/vol) isopropanol/10% (vol/
vol) acetic acid and fluorographed as described (19).
Isolation of Poly(A)-Containing RNA from Fetal Liver and
Fetal Liver Pre-B Cells. Total RNA was extracted from intact
fetal livers or adult spleens that had been stored at -70°C or
from purified pre-B cells by a modification of the guanidine HCl
procedure (20). Whole livers were sonicated (four times for 15
sec each) in extraction buffer (15 ml/g of tissue) to disrupt the
cells. Poly(A)-containing RNA was selected on oligo(dT)-cellu-
lose as described (21).
Size Analysis of Immunoglobulin RNA. Poly(A)-containing
RNA was fractionated by electrophoresis on 1.4% (wt/vol) agar-
ose gels containing 5 mM methylmercuric hydroxide (22) at 100
V for approximately 4 hr and then transferred to diazotized pa-
per (23).
Preparation of Probes. Recombinant plasmids pABpu-1,
pABIu-3, and pABK-1 were derived by A. Bothwell and used
under conditions that conform with the National Institutes of
Health guidelines for recombinant DNA research. The whole
plasmids were labeled by nick translation (24) to specific activ-
ities of 1-4 x 108 cpm/,ug except in the quantitation experi-
ment, in which the 400-bp insert of K chain sequences in pABK-
1 ada 400-bp Pst fragment from pABu-3 were purified before
nick translation.
Hybridization was allowed to proceed with 6 x 106 cpm of
probe per 100 cm2 of paper for 24 hr in the presence of 10%
(wt/vol) dextran sulfate (23). Unhybridized probe was removed
from the paper by washing at 370C for 3 hr with five changes
of 50% (vol/vol) formamide/0.75 M NaCV/0.075 M Na citrate;
2 hr with two changes of 50% formamide/0. 15 M NaCV/0.015
M Na citrate, and finally for 1 hr at 680C with three changes in
0.015 M NaCI/0.015 M Na citrate/1% sodium dodecyl sulfate.
The paper was then blotted dry and analyzed by autoradiography.
RESULTS
Metabolic Labeling of Immunoglobulins in Fetal and Neo-
natal Liver Cells. To determine the pattern of Ig biosynthesis
in lymphoid cells of the developing mouse embryo, cells from
fetal and neonatal livers were labeled with [3S]methionine, and
cell extracts were analyzed by immunoprecipitation. When
polyspecific anti-mouse Ig serum was used to precipitate Ig-re-
lated polypeptides from detergent-solubilized extracts of liver
cells from 18-day embryos, a polypeptide with the electropho-
retic mobility of an Ig pk heavy chain was evident in the pre-
cipitate, but there was no detectable light chain (Fig. 1, lane
B). Nonimmune rabbit serum failed to precipitate any Ig-re-
lated polypeptides (Fig. 1, lane A). Precipitation of the apparent
,u chain polypeptide could be blocked with affinity-purified
IgM from myeloma MOPC-104E, indicating that it was a u
chain (Fig. 1, lane C). By contrast, extracts of cells isolated from
neonatal livers (21 days of gestation) contained both A heavy
and light chains (Fig. 1, lane D). Using this methodology, we
first detected ,u heavy chains as early as day 17 of gestation but
did not detect significant amounts of light chains until day 19.
Absence of Proteolytic Degradation in Fetal Liver Extracts.
A mixture of protease inhibitors and gentle extraction condi-
tions were used in these studies to minimize possible protein
degradation (25). To test whether residual proteolytic activity
in extracts of the fetal tissue was capable of specifically de-
A B C D
FIG. 1. Metabolic labeling of precleared extracts of 7 x 106 fetal
and neonatal liver cells. Lanes: A, Eighteen-day embryo cells precip-
itated with normal rabbit serum; B, 18-day embryo cells precipitated
with polyvalent rabbit anti-mouse Ig; C, 18-day embryo cells precipi-
tated with polyvalent rabbit anti-mouse Ig and 10 pgg of purified
MdPC-104E IgM; D, 21-day neonatal liver cells precipitated with poly-
valent rabbit anti-mouse 1g. IA, A chain; L, light chain.
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grading labeled light chains, a mixing experiment was per-
formed. [35S]Methionine-labeled extracts of 21-day livers,
which contained labeled light chains, were mixed with equal
amounts of unlabeled extracts of embryonic livers. The same
amount of labeled light chain was recovered when the 21-day
extract was mixed with unlabeled extracts from 17-day, 18-day,
or 21-day liver cells (Fig. 2, lanes D, E, and F). Unlabeled ex-
tracts of 21-day liver contained no endogenous protease inhib-
itors that would allow detection of light chains in labeled 17-day
or 18-day liver extracts (Fig. 2, lanes B and C).
Surface Immunoglobulin Phenotype of pu-Only Cells. At day
19 of gestation, liver cells synthesized both A and light chains(Fig. 3, lane A). However, there, was a great excess of tL chain
over light chain. When 19-day liver cells were fractionated by
adsorption to petri dishes coated with rabbit anti-mouse Ig an-
tibodies (16), adherent surface Ig-positive cells could be sepa-
rated from the nonadherent surface Ig-negative fraction. The
Ig-related polypeptides in labeled extracts of these two cell
populations were compared. Light chain synthesis could not be
detected in the surface Ig-negative population (Fig. 3, lane C),
but light chains were synthesized by cells expressing Ig on their
surface (Fig. 3, lane B). Neither of these fractions secrete sig-
nificant amounts of Ig into the culture medium (data not
shown).
Detection of Immunoglobulin mRNA During Ontogeny. To
examine pL heavy and light chain mRNA levels in fetal liver cells,
the poly(A)-containing RNA was extracted from livers taken
from embryos at days 15-21 of gestation. The RNA was size-
fractionated by electrophoresis through methylmercuric hy-
droxide-containing agarose gels, transferred to diazotized pa-
per, and hybridized with 32P-labeled DNA from molecular
clones of ,A chain or K chain cDNA (Fig. 4). When a probe rep-
resenting the 770 3'-terminal nucleotides of A chain mRNA (6)
was used, mRNAs 2.4-3.0 kb in length were evident (Fig. 4A).
The 3. 0- and 2.4-kb species were predominant in fetal liver cells
A B C D E F
F- ~ - m_ _
L -
FIG. 2. Inhibition of protease activity in extracts of fetal liver
cells. Detergent-solubilized extracts of 107 [35S]methionine-labeled
cells were mixed with extracts of 10' unlabeled cells that had been in-
cubated similarly but without [35S]methionine. After mixing, the ex-
tracts were precleared together with normal serum and fixed S. aureus
before immunoprecipitation with rabbit anti-mouse Ig. Lanes: A,
[35S]Methionine-labeled cytoplasmic IgM marker from MOPC-104E
myeloma; B, labeled 17-day fetal liver cell extract mixed with unla-
beled 21-day neonatal liver extracts; C, labeled 18-day extract mixed
with 21-day unlabeled extract; D, E, and F, labeled 21-day neonatal
liver extract mixed with unlabeled 17-, 18-, and 21-day extracts re-
spectively. ,u, ,u chain; L, light chain.
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FIG. 3. Fractionation of surface Ig-positive and -negative 19-day
fetal liver cells on anti-Ig-coated petri dishes. Lanes: A, Precipitation
with polyvalent rabbit anti-mouse Ig from an extract of 107 unfrac-
tionated cells; B, precipitation from the adherent population isolated
from 107 unfractionated cells; C, precipitation from the nonadherent
population isolated from 107 unfractionated cells. A, ,u chain; L, light
chain.
obtained between days 15 and 17; thereafter, a 2.7-kb species
predominated (Fig. 4A Inset; Fig. 4C). The 2.7-kb ,u chain
mRNA is the same size as that encoding the membrane-bound
form of ,t protein (6, 7); when a DNA probe specific for the exon
specifying the membrane-binding portion of .m protein was
used as a probe (8), the 2.7-kb ,u chain-specific RNA in 19-day
fetal liver was labeled (data not shown), indicating that the j.m
mRNA is the predominant species in these cells. The 3.0- and
2.4-kb RNA in early fetal liver have counterparts in a variety
of lymphoid cells and may not represent RNA that could encode
an authentic it protein (unpublished data). The pattern of A
chain RNA in 19-day fetal liver cells is similar to that in B lym-
phocytes and in A-MuLV-transformed , chain-only cells (Fig.
4C, lane 12; ref. 6; unpublished data).
When a [32P]DNA probe for K chain mRNA was used, the
first detectable RNA was found in 18-day liver cells (Fig. 4B).
Both 1.2-kb mature-size K chain nRNA and an 0.8-kb mRNA
that could encode a fragment of K chain-related protein were
found in 18- and 19-day fetal liver cells. Later in development,
only the 1.2-kb species was detected in both fetal liver and
spleen cell RNA (Fig. 4C; ref. 26). A K chain RNA pattern sim-
ilar to that found in 18- to 19-day fetal liver also could be de-
tected in certain A-MuLV-induced ,u chain-negative cell lines
(Fig. 4C, lane 11) and also is observed in certain myeloma lines
(26).
To determine the relative abundance of /Lm and K chain
mRNAs during embryonic development, a mixed probe was
prepared. Approximately equal amounts of DNA representing
400-base regions of the u chain and K chain mRNAs were mixed
and labeled together with 32P. To test whether the probe hy-
bridized equivalently to the two types of RNA and whether the
response of the autoradiographic detection method was linearly
related to RNA concentration, serial 50% dilutions of mature
Immunology: Siden et al.
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FIG. 4. Size and quantity of IgRNAfound in fetal liver cells during
late gestation. Approximately 10 ,ug of poly(A)-containing RNA from
days 15-19 of gestation (lane designation) was fractionated and hy-
bridized with approximately 5 x 10 cpm of nick-translated probe. (A)
,u chain RNA sequences detected by homology to labeled pABA-1 (108
cpm /flg). Inset, shorter exposure of the same experiment. (B) K chain
sequences hybridizing to pABK-1. (C) Amounts of various RNAs hy-
bridized with a probe prepared by mixing equal amounts of 400-bp
fragments of pABK-1 and pABAi-3 and nick-translating these together
to a specific activity of 4 x 108dpm/ug (1 dpm= 16.7 mBq). Lanes: 1-5,
adult spleen cells (220 ng, 110 ng, 55 ng, 28 ng, 14 ng, respectively);
6, blank; 7-10, fetal liver cells [21-day cells (7.5 pg), day-19 surface Ig-
negative cells (6.5 pg), 19-day unfractionated cells (7.5 pZg), 18-day cells
(9 ,ug), respectively]; 11 and 12, tumor cells [cell line 18-48 (10) (3 pg),
cell line 3-1 (10) (2 pig), respectively].
spleen RNA were fractionated, transferred to paper, hybridized
to the probe, and autoradiographed (Fig. 4C, lanes 1-5). Ap-
proximately equal intensity chain and K chain signals were
detected at each dilution, and densitometry showed that a linear
decrease in signal intensity occurred with dilution (data not
shown). By day 21 of gestation, the probe showed equal
amounts of 2.7-kb p.m and 1.2-kb K chain mRNA (lane 7). At
day 18, however, the p.Am mRNA was clearly in excess (lane 10).
The relative amount of K chain-specific mRNA increased 2- to
3-fold by day 19 of development (lane 9) and began to approach
the amount of pAm mRNA.
To examine the RNAs in surface Ig-negative cells of 19-day
liver, surface Ig-positive cells were removed using dishes
coated with anti-Ig antibody. The surface Ig-negative cells had
an increased ratio of pAm mRNA to K chain mRNA (Fig. 4C, lane
8) when compared to the unfractionated cells (lane 9). They also
had enriched amounts of the 0.8-kb K chain-related RNA rel-
ative to the 1.2-kb K chain RNA.
DISCUSSION
These data show that at day 18 of embryonic development,
when intracellular Ig-related polypeptides first become evident
in fetal liver by biosynthetic labeling under our conditions, the
cells make chains but no detectable K chains. This result is
in agreement with the evidence from Levitt and Cooper (14)
who found chain-only synthesis in the fetal liver as early as
day 15 of development. As development proceeds to birth at
19 days, K chain synthesis becomes evident and soon equals pu
heavy chain synthesis. The surface Ig-negative cells at day 19,
however, still make no detectable K chain protein. Therefore,
we conclude that' at least in fetal and neonatal liver, the puchain-
only phenotype is characteristic of the majority of pre-B lym-
phocytes (defined as cells with cytoplasmic Ig but no surface
Ig).
These changes in Ig production during B-lymphocyte de-
velopment are paralleled by changes in mRNA levels. At day
18, the 2.7-kb A.U mRNA greatly exceeds the 1.2-kb K chain
mRNA, reflecting the disparity in chain and K chain proteins.
By day 19, the levels of K chain mRNA have risen, although the
surface Ig-negative cells present at this time still show the pre-
ponderance of the 2.7-kb p.. mRNA typical of the 18-day cells.
The mRNA for a given Ig polypeptide becomes evident before
detectable levels of the polypeptide itself appears; there is, for
example, relatively more K chain mRNA evident at day 18 than
there is K chain protein.
Our examination of light chain synthesis focused on K chains
because this isotype is known to represent the vast majority of
light chain made by the adult animal. In exploratory experi-
ments, we determined that 21-day liver extracts contain both
A chain protein, determined by radioimmunoassay, and A chain-
specific RNA, determined by quantitative hybridization (26).
These comprised only about 5% of the total light chain protein
and RNA (unpublished data). This result implies that K chain-
producing cells arise in the liver much more frequently than do
A chain-producing cells. y heavy chain RNAs were only found
in small amounts compared to chain-specific RNA (unpub-
lished data).
Ig has been detected in the murine fetal liver as early as day
10 of gestation (25). Using techniques other than metabolic la-
beling, it has been claimed that surface IgM (p. chain and light
chain) can be detected on fetal liver cells by day 13 of gestation
(27, 28). The metabolic labeling technique we have used will
detect the predominant synthetic activity of liver cells but could
well miss the synthetic activities of rare cells; thus, it is possible
that some light chain-synthesizing cells appear by day 18 of
gestation but could not be detected by our techniques. It is
evident, however, that over 90% of the Ig-related polypeptides
synthesized by fetal liver cells is pu chain. This pu chain-only
phenotype is mirrored by certain A-MuLV-transformed cells
that contain cytoplasmic pu chain but not light chains (10).
Our results differ from those of Levitt and Cooper (14) in that
we were unable to detect significant levels of secretion of pu
chain peptides by pre-B lymphocytes isolated at day 18 or later
in gestation. Because we cannot detect secretion of chains
and because we find a predominance of 2.7-kb p.m mRNA over
the 2.4-kb ps mRNA, we believe that the majority of chain
polypeptides made by pre-B lymphocytes are of the pLm type.
The lack of surface IgM on the cells presumably reflects a block
in the normal processing scheme for IgM, possibly as a result
of the lack of light chains needed to make a finished Ig mole-
cule. Even if these early lymphocytes make some ,us protein
(and there may be some 2.4-kb ps mRNA in the earliest fetal
liver cells), successful secretion might also be blocked.
The difference in protein and mRNA patterns between sur-
A
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face Ig-negative and surface Ig-positive cells implies a close
coordination between the onset of light chain synthesis and the
appearance on the cells of sufficient surface IgM molecules to
enable binding to an anti-Ig-coated petri dish. Whereas it is
possible that surface A chain could be made before surface IgM,
it seems reasonable to suggest that surface Ig is deposited only
after light chain synthesis is activated. Such a suggestion implies
a pathway of B-lymphocyte maturation involving first activation
of 1L chain synthesis followed later by activation of light chain
synthesis. When tL chain alone is made, the polypeptide is un-
able to mature to become a surface molecule and is degraded
in the cell, much as it is in the A-MuLV-transformed tumor cells
(10). When light chain synthesis is activated, complete IgM
molecules can then assemble and be transported toethe cell sur-
face. The appearance of the human histocompatibility antigen
proteins on the cell surface requires association between the
heavy chain and the /32-microglobulin light chain (29, 30). This
suggests that association of multiple polypeptides may be re-
quired before surface expression of certain membrane-associ-
ated proteins can be accomplished.
The observation that the predominant form of ,u chain mRNA
in 18- to 21-day fetal liver is the 2.7-kb Aum mRNA correlates
with the fact that the virgin B lymphocyte has mainly surface
Ig. The predominance of secreted Ig is only evident in the more
mature products of B-lymphocyte activation. The 2.4-kb tL
chain-related RNA found even in the earliest fetal liver cells
could represent ,s mRNA but more likely has another origin.
It is always accompanied by a 3.0-kb 1L chain RNA, and un-
published data suggest that this doublet of RNA represents a
transcriptional activity of the u chain constant region that does
not lead to a normal tL chain protein.
In summary, the available data suggest that early B-lympho-
cyte development proceeds through two stages. First, u chain-
only cells (pre-B lymphocytes) appear that lack light chain or
light chain mRNA. The major form of protein and mRNA in
these cells is um, but the protein cannot be processed to the cell
surface. This cell could presumably expand as a clone until the
next stage commences. Second, light chain synthesis starts,
preceded by rearrangement of the light chain genes. Light
chain rearrangements continue until a light chain is produced
that can effectively combine with the yt chain. The resultant(p.L)2 dimers mature into surface IgM molecules. At that point,
the cell becomes a resting virgin B lymphocyte awaiting anti-
genic stimulation.
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